May, 01 2019, 12:00am EDT
For Immediate Release
Contact:
Paul Kawika Martin, Peace Action, 951-217-7285 cell, pmartin@peace-action.org
Senate to Vote Soon on Overriding Trump's Veto of Yemen War Powers Resolution
WASHINGTON
Expert Contact:
Paul Kawika Martin, Peace Action, 951-217-7285 cell, pmartin@peace-action.org
For over twenty years, Paul Kawika (ca vee' ca) Martin, Peace Action's senior director for policy and political affairs, has worked with numerous environmental, peace, animal rights and human rights organizations including Greenpeace and the Nobel prize-winning Physicians for Social Responsibility. As Peace Action's chief lobbyist, Paul has been in close contact with all the key legislators and NGO leaders working on S.J.Res. 7 and has lobbied extensively in support of it. In 2018, he penned an op-ed published in the Hill entitled "End America's unauthorized war in Yemen," urging Congress to pass an earlier version of the Yemen war powers resolution. Paul is currently on the board of the National Priorities Project, PeacePAC and the Herbert Scoville Jr. Peace Fellowship.
Procedural Background:
The Senate is expected to vote as soon as tomorrow afternoon (Thursday, 5/2) on the question of overriding President Trump's veto of S.J.Res. 7, legislation directing the president to withdraw U.S. support for the war in Yemen. The vote will likely be a procedural vote, such as a motion to table, rather than an up or down vote to override, and will likely occur after votes on nominations. The Senate passed S.J.Res. 7 on March 13, 2019 in a vote of 54 - 46, and the House followed suit on April 4, 2019 in a vote of 247 - 175, sending the legislation to the president's desk.
Overriding President Trump's veto will require two-thirds of both houses of Congress--67 votes in the Senate, and 290 votes in the House. As the bill originated in the Senate, the Senate will take up the question of a vote to override first, and if it passes with a two-thirds majority vote, the question will move to the House.
As all Senate Democrats and the two Independent senators who caucus with the Democrats voted for the resolution, assuming all who supported the resolution will support a vote to override, 13 Republicans who voted against the resolution would need to support the vote to override for the effort to succeed, making its success unlikely. If the Senate votes to override Trump's veto, 43 representatives who voted against the legislation in the House would have to support a vote to override for the legislation to become law.
Political Background:
This vote is the culmination of years of work by congressional champions of a more just and responsible U.S. foreign policy, and by a coalition of peace groups, human rights groups, and other advocacy groups (representing millions of Americans) who have organized and lobbied tirelessly to end U.S. support for the brutal Saudi and UAE-led war in Yemen.
Ahead of this expected vote, the humanitarian situation in Yemen is as dire as ever. Roughly 24 million people, almost 80 percent of Yemen's population, rely on humanitarian aid, and over 14 million "require immediate assistance in order to save and sustain their lives," according to the United Nations.
As the 2020 election draws closer, U.S. involvement in Yemen as well as the broader debate around congressional war powers will be important foreign policy litmus tests for candidates hoping to differentiate themselves from a president who has vetoed the will of a majority of Congress, and a majority of the American people.
Next Steps for Congress:
Should the vote or votes to override President Trump's veto fail to secure a two-thirds majority in both houses, Congress still has other options for ending U.S. support for the war in Yemen. As budget processes move forward, Congress can deny funding for ongoing U.S. support for the war. Congress can also work to block arms sales, which remain one of the most significant forms of U.S. support for the war.
The Arms Export Control Act gives members of Congress the power to introduce privileged legislation to force votes on whether or not to allow arms sales of a certain value to move forward. Senators have already invoked that power twice--once in 2016 and once in 2017--in efforts to block arms sales to Saudi Arabia, though both efforts failed to secure support from a majority of Congress. But a lot has changed since then and a majority of Congress may now support blocking arms sales to the coalition.
Key committee members may also be able to block arms sales without a majority of Congress. In June of 2017, Senator Bob Corker exerted his power as Chair of the Senate Foreign Relations Committee to block arms sales to Saudi Arabia, Qatar, and several other Gulf nations over a diplomatic spat between Saudi Arabia and Qatar. In June of 2018, Senator Bob Menendez (D-NJ) used his position as the ranking member of the Senate Foreign Relations Committee to prevent a proposed sale of precision-guided munitions to Saudi Arabia and the United Arab Emirates.
Peace Action is the United States' largest peace and disarmament organization with over 100,000 members and nearly 100 chapters in 34 states, works to achieve the abolition of nuclear weapons, promote government spending priorities that support human needs and encourage real security through international cooperation and human rights.
LATEST NEWS
Dems Demand Answers as Trump Photo Disappears From DOJ Online Epstein Files
"What else is being covered up?"
Dec 20, 2025
Congressional Democrats on Saturday pressed US Attorney General Pam Bondi for answers regarding the apparent removal of a photo showing President Donald Trump surrounded by young female models from Friday's Department of Justice release of files related to the late convicted child sex criminal Jeffrey Epstein.
Amid the heavily redacted documents in Friday's DOJ release was a photo of a desk with an open drawer containing multiple photos of Trump, including one of him with Epstein and convicted child sex trafficker Ghislaine Maxwell and another of him with the models.
However, the photo—labeled EFTA00000468 in the DOJ's Epstein Library—was no longer on the site as of Saturday morning.
"This photo, file 468, from the Epstein files that includes Donald Trump, has apparently now been removed from the DOJ release," Democrats on the House Oversight Committee noted in a Bluesky post. "AG Bondi, is this true? What else is being covered up? We need transparency for the American public."
This photo, file 468, from the Epstein files that includes Donald Trump has apparently now been removed from the DOJ release.AG Bondi, is this true? What else is being covered up? We need transparency for the American public.
[image or embed]
— Oversight Dems (@oversightdemocrats.house.gov) December 20, 2025 at 9:30 AM
Numerous critics have accused the Trump administration of a cover-up due to the DOJ's failure to meet a Friday deadline to release all Epstein-related documents and heavy redactions—including documents of 100 pages or more that are completely blacked out—to many of the files.
Deputy Attorney General Todd Blanche responded to the criticism by claiming that "the only redactions being applied to the documents are those required by law—full stop."
"Consistent with the statute and applicable laws, we are not redacting the names of individuals or politicians unless they are a victim," he added.
Earlier this year, officials at the Federal Bureau of Investigation reportedly redacted Trump's name from its file on Epstein, who was the president's longtime former friend and who died in 2019 in a New York City jail cell under mysterious circumstances officially called suicide while facing federal child sex trafficking and conspiracy charges.
Trump has not been accused of any crimes in connection with Epstein.
House Oversight Committee Ranking Member Robert Garcia (D-Calif.) said during a Friday CNN interview that the DOJ only released about 10% of the full Epstein files.
The DOJ is breaking the law by not releasing the full Epstein files. This is not transparency. This is just more coverup by Donald Trump and Pam Bondi. They need to release all the files, NOW.
[image or embed]
— Congressman Robert Garcia (@robertgarcia.house.gov) December 19, 2025 at 5:06 PM
"The DOJ has had months and hundreds of agents to put these files together, and yet entire documents are redacted—from the first word to the last," Garcia said on X. "What are they hiding? The American public deserves transparency. Release all the files now!"
In a joint statement Friday, Garcia and House Judiciary Committee Ranking Member Jamie Raskin (D-Md.) said, "We are now examining all legal options in the face of this violation of federal law."
"The survivors of this nightmare deserve justice, the co-conspirators must be held accountable, and the American people deserve complete transparency from DOJ," they added.
Rep. Ro Khanna (D-Calif.)—who along with Rep. Thomas Massie (R-Ky.) introduced the Epstein Files Transparency Act, which was signed into law by Trump last month and required the release of all Epstein materials by December 19—said in a video published after Friday's document dump that he and Massie "are exploring all options" to hold administration officials accountable.
"It can be the impeachment of people at Justice, inherent contempt, or referring for prosecution those who are obstructing justice," he added.
Keep ReadingShow Less
Israeli Forces Massacre 6 Palestinians Celebrating Wedding at Gaza School Shelter
"This isn't a truce, it's a bloodbath," said a relative of some of the victims, who included women, an infant, and a teenage girl.
Dec 20, 2025
Funerals were held Saturday in northern Gaza for six people, including children, massacred the previous day by Israeli tank fire during a wedding celebration at a school sheltering displaced people, as the number of Palestinians killed during the tenuous 10-week ceasefire rose to over 400.
On Friday, an Israel Defense Forces (IDF) tank blasted the second floor of the Gaza Martyrs School, which was housing Palestinians displaced by the two-year war on Gaza in the al-Tuffah neighborhood of Gaza City.
Al Jazeera and other news outlets reported that the attack occurred while people were celebrating a wedding.
Al-Shifa Hospital director Mohammed Abou Salmiya said those slain included a 4-month-old infant, a 14-year-old girl, and two women. At least five others were injured in the attack.
"It was a safe area and a safe school and suddenly... they began firing shells without warning, targeting women, children and civilians," Abdullah Al-Nader—who lost relatives including 4-month-old Ahmed Al-Nader in the attack—told Agence France-Presse.
Witnesses said IDF troops subsequently blocked first responders including ambulances and civil defense personnel from reaching the site for over two hours.
"We gathered the remains of children, elderly, infants, women, and young people," Nafiz al-Nader, another relative of the infant and others killed in Friday's attack, told reporters. "Unfortunately, we called the ambulance and the civil defense, but they couldn't get by the Israeli army."
The IDF said that “during operational activity in the area of the Yellow Line in the northern Gaza Strip, a number of suspicious individuals were identified in command structures," and that "troops fired at the suspicious individuals to eliminate the threat."
The Yellow Line is a demarcation boundary between areas of Gaza under active Israeli occupation—more than half of the strip's territory, including most agricultural and strategic lands—and those under the control of Hamas.
"The claim of casualties in the area is familiar; the incident is under investigation," the IDF said, adding that it "regrets any harm to uninvolved parties and acts as much as possible to minimize harm to them."
Since the October 7, 2023 Hamas-led attack on Israel, more than 250,000 Palestinians have been killed or wounded by Israeli forces, including approximately 9,500 people who are missing and presumed dead and buried beneath rubble. Classified IDF documents suggest that more than 80% of the Palestinians killed by Israeli forces were civilians.
Around 2 million Palestinians have also been displaced—on average, six times—starved, or sickened in the strip.
Gaza officials say at least 401 Palestinians have been killed since a US-brokered ceasefire between Israel and Hamas took effect on October 10. Gaza's Government Media Office says Israel has violated the ceasefire at least 738 times.
"This isn't a truce, it's a bloodbath," Nafiz al-Nader told Agence France-Presse outside al-Shifa Hospital on Saturday.
Israel says Hamas broke the truce at least 32 times, with three IDF soldiers killed during the ceasefire.
Israeli Prime Minister Benjamin Netanyahu and Yoav Gallant, his former defense minister, are fugitives from the International Criminal Court in The Hague, where they are wanted for alleged war crimes and crimes against humanity in Gaza, including murder and forced starvation.
Israel is also facing a genocide case filed by South Africa at the International Court of Justice, also in The Hague. A United Nations commission, world leaders, Israeli and international human rights groups, jurists, and scholars from around the world have called Israel's war on Gaza a genocide.
Friday's massacre came as Steve Witkoff, President Donald Trump's Mideast envoy, other senior US officials, and representatives of Egypt, Qatar, Turkey, and the United Arab Emirates met in Miami to discuss the second phase of Trump's peace plan, which includes the deployment of an international stabilization force, disarming Hamas, the withdrawal of IDF troops from the strip, and the establishment of a new government there.
Keep ReadingShow Less
Trump's 9 New Prescription Drug Deals 'No Substitute' for Systemic Reform
"Patients are overwhelmingly calling on Congress to do more to lower prescription drug prices by holding Big Pharma accountable and addressing the root causes of high drug prices," said one campaigner.
Dec 19, 2025
"Starting next year, American drug prices will come down fast and furious and will soon be the lowest in the developed world," President Donald Trump claimed Friday as the White House announced agreements with nine pharmaceutical manufacturers.
The administration struck most favored nation (MFN) pricing deals with Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi. The president—who has launched the related TrumpRx.gov—previously reached agreements with AstraZeneca, EMD Serono, Eli Lilly, Novo Nordisk, and Pfizer.
"The White House said it has made MFN deals with 14 of the 17 biggest drug manufacturers in the world," CBS News noted Friday. "The three drugmakers that were not part of the announcement are AbbVie, Johnson & Johnson, and Regeneron, but the president said that deals involving the remaining three could be announced at another time."
However, as Trump and congressional Republicans move to kick millions of Americans off of Medicaid and potentially leave millions more uninsured because they can't afford skyrocketing premiums for Affordable Care Act (ACA) plans, some critics suggested that the new drug deals with Big Pharma are far from enough.
"When 47% of Americans are concerned they won't be able to afford a healthcare cost next year, steps to reduce drug prices for patients are welcomed, especially by patients who rely on one of the overpriced essential medicines named in today's announcement," said Merith Basey, CEO of Patients for Affordable Drugs Now, in a statement.
"But voluntary agreements with drug companies—especially when key details remain undisclosed—are no substitute for durable, system-wide reforms," Basey stressed. "Patients are overwhelmingly calling on Congress to do more to lower prescription drug prices by holding Big Pharma accountable and addressing the root causes of high drug prices, because drugs don't work if people can't afford them."
As the New York Times reported Friday:
Drugs that will be made available in this way include Amgen's Repatha, for lowering cholesterol, at $239 a month; GSK's asthma inhaler, Advair Diskus, at $89 a month; and Merck's diabetes medication Januvia, at $100 a month.
Many of these drugs are nearing the end of their patent protection, meaning that the arrival of low-cost generic competition would soon have prompted manufacturers to lower their prices.
In other cases, the direct-buy offerings are very expensive and out of reach for most Americans.
For example, Gilead will offer Epclusa, a three-month regimen of pills that cures hepatitis C, for $2,492 a month on the site. Most patients pay far less using insurance or with help from patient assistance programs. Gilead says on its website that "typically a person taking Epclusa pays between $0 and $5 per month" with commercial insurance or Medicare.
While medication prices are a concern for Americans who face rising costs for everything from groceries to utility bills, the outcome of the ongoing battle on Capitol Hill over ACA tax credits—which are set to expire at the end of the year—is expected to determine how many people can even afford to buy health insurance for next year.
The ACA subsidies fight—which Republicans in the US House of Representatives ignored in the bill they passed this week before leaving Capitol Hill early—has renewed calls for transitioning the United States from its current for-profit healthcare system to Medicare for All.
"At the heart of our healthcare crisis is one simple truth: Corporations have too much power over our lives," Rep. Pramila Jayapal (D-Wash.), former chair of the Congressional Progressive Caucus, said on social media Friday. "Medicare for All is how we take our power back and build a system that puts people over profits."
Jayapal reintroduced the Medicare for All Act in April with Rep. Debbie Dingell (D-Mich.) and Senate Health, Education, Labor, and Pensions Committee Ranking Member Bernie Sanders (I-Vt.). The senator said Friday that some of his top priorities in 2026 will be campaign finance reform, income and wealth inequality, the rapid deployment of artificial intelligence, and Medicare for All.
Earlier this month, another backer of that bill, US Sen. Chris Van Hollen (D-Md.), said: "We must stop tinkering around the edges of a broken healthcare system. Yes, let's extend the ACA tax credits to prevent a huge spike in healthcare costs for millions. Then, let's finally create a system that puts your health over corporate profits. We need Medicare for All."
It's not just progressives in Congress demanding that kind of transformation. According to Data for Progress polling results released late last month, 65% of likely US voters—including 78% of Democrats, 71% of Independents, and 49% of Republicans—either strongly or somewhat support "creating a national health insurance program, sometimes called 'Medicare for All.'"
Keep ReadingShow Less
Most Popular


